// App-Quantinova.ai

933 : Real-world treatment patterns and clinical outcomes in patients with metastatic NSCLC after receiving first-line pembrolizumab with pemetrexed/platinum chemotherapy in the US oncology network

Researchers

Presenter

  • Jerome Goldschmidt

Principal Investigators

  • Srinivas Annavarapu

  • Divea Venkatasetty

  • Melissa Santorelli

  • Thomas Burke

  • Nathan Pennell

Medical Centers

  • Cleveland Clinic Foundation, Cleveland, Ohio, United States

  • The US Oncology Network, Blacksburg, VA, United States

  • Ontada, Irving, TX, United States

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non Small Cell Lung cancer

Biomarkers

  • Programmed death-ligand 1

Drug/Treatment

  • Pembrolizumab

  • Pemetrexed

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved